AI is having amazing effects on the world of medicine. It's helping us to more capably diagnose patients. It's providing assistance with radiology imaging. It's working with pathogens and microbes and very small things.
In terms of the scope of AI in medicine, it’s helping us with things at all scales, from a molecular level, all the way up to a patient care level.All three of these companies were represented in a panel at the IIA event this spring. We also had Ava Amini, senior researcher at Microsoft, who added her own insights to thoughts on enterprise use of AI in this sector.GNS is pursuing advances in biomedicine. Some of it is around new drugs – figuring out how patients will respond, for example.
Some suggested there was a shift in biology, where we now look at the ability to generate insights without a concrete or predetermined hypothesis.“The rules have changed,” Ziegler said, also talking about the alignment of three things: scale of model, scale of compute, and scale of data. “As a community, we haven't even begun to scrape 1% of what we can do with this glorious world that we live in.
Those are some of the critical things that these three companies are doing, and they’re just some of the many disruptors that are working their magic in a field that's always been science-based, but only now has begun to be highly technologized in this way. I want to continue to bring these kinds of insights here, and highlight a lot of what's going on as we see it up close with our panelists and speakers, and all of the participation that we see from people and institutions.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: engadget - 🏆 276. / 63 続きを読む »
ソース: verge - 🏆 94. / 67 続きを読む »
ソース: ForbesTech - 🏆 318. / 59 続きを読む »
ソース: FoxBusiness - 🏆 458. / 53 続きを読む »
ソース: physorg_com - 🏆 388. / 55 続きを読む »
ソース: KJNBNews - 🏆 526. / 51 続きを読む »